These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 23544160)

  • 41. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
    Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
    Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth.
    Mulet X; Moyá B; Juan C; Macià MD; Pérez JL; Blázquez J; Oliver A
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4560-8. PubMed ID: 21807976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
    Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
    [No Abstract]   [Full Text] [Related]  

  • 44. Characterisation of OXA-258 enzymes and AxyABM efflux pump in Achromobacter ruhlandii.
    Papalia M; Traglia G; Ruggiero M; Almuzara M; Vay C; Gutkind G; Ramírez MS; Radice M
    J Glob Antimicrob Resist; 2018 Sep; 14():233-237. PubMed ID: 29649588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of antibiotic resistance in Klebsiella pneumoniae exposed to sequential in vitro antibiotic treatments.
    Kim J; Jo A; Chukeatirote E; Ahn J
    Ann Clin Microbiol Antimicrob; 2016 Dec; 15(1):60. PubMed ID: 27938381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The mechanism of resistance of Pseudomonas aeruginosa to beta-lactam antibiotics and clinical significance.
    Song J; Ruan Q; Qi J; Gao M; Wang Y
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(4):339-42. PubMed ID: 12674775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Influence of Efflux Pump Inhibitors on the Activity of Non-Antibiotic NSAIDS against Gram-Negative Rods.
    Laudy AE; Mrowka A; Krajewska J; Tyski S
    PLoS One; 2016; 11(1):e0147131. PubMed ID: 26771525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective trihydroxyazepane NagZ inhibitors increase sensitivity of Pseudomonas aeruginosa to β-lactams.
    Mondon M; Hur S; Vadlamani G; Rodrigues P; Tsybina P; Oliver A; Mark BL; Vocadlo DJ; Blériot Y
    Chem Commun (Camb); 2013 Dec; 49(93):10983-5. PubMed ID: 24136176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of interaction between outer membrane permeability and beta-lactamase production on resistance to beta-lactam agents in gram-negative bacteria.
    Sawai T; Yamaguchi A; Hiruma R
    Rev Infect Dis; 1988; 10(4):761-4. PubMed ID: 3055174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Constructing and deconstructing the bacterial cell wall.
    Fisher JF; Mobashery S
    Protein Sci; 2020 Mar; 29(3):629-646. PubMed ID: 31747090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-level resistance to meropenem in clinical isolates of Pseudomonas aeruginosa in the absence of carbapenemases: role of active efflux and porin alterations.
    Chalhoub H; Sáenz Y; Rodriguez-Villalobos H; Denis O; Kahl BC; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2016 Dec; 48(6):740-743. PubMed ID: 28128097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa.
    Askoura M; Mottawea W; Abujamel T; Taher I
    Libyan J Med; 2011 May; 6():. PubMed ID: 21594004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A phenylalanine-arginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides.
    Mamelli L; Amoros JP; Pagès JM; Bolla JM
    Int J Antimicrob Agents; 2003 Sep; 22(3):237-41. PubMed ID: 13678827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
    Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
    J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa.
    Mao W; Warren MS; Lee A; Mistry A; Lomovskaya O
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2001-7. PubMed ID: 11408215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam.
    McPherson CJ; Aschenbrenner LM; Lacey BM; Fahnoe KC; Lemmon MM; Finegan SM; Tadakamalla B; O'Donnell JP; Mueller JP; Tomaras AP
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6334-42. PubMed ID: 23027195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic Actions of Benzyl Isothiocyanate with Ethylenediaminetetraacetic Acid and Efflux Pump Inhibitor Phenylalanine-Arginine β-Naphthylamide Against Multidrug-Resistant
    Lin KH; Lo CC; Chou MC; Yeh TH; Chen KL; Liao WY; Lo HR
    Microb Drug Resist; 2020 May; 26(5):468-474. PubMed ID: 31755808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
    Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system.
    Zhang L; Li XZ; Poole K
    Antimicrob Agents Chemother; 2000 Feb; 44(2):287-93. PubMed ID: 10639352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The bacterial outer membrane as a drug barrier.
    Hancock RE
    Trends Microbiol; 1997 Jan; 5(1):37-42. PubMed ID: 9025234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.